Related Experiment Videos
[Percutaneous nephrostomy in neoplasm patients: when?]
1Servizio di Radiologia, Ospedale Policlinico S. Orsola Malpighi, Bologna.
La Radiologia Medica
|December 1, 1991
Summary
Urinary diversion for advanced cancer patients with renal failure offers limited survival benefits, with high mortality rates within one year. Patient selection criteria are crucial for optimizing outcomes and quality of life.
Area of Science:
- Oncology
- Nephrology
- Urology
Background:
- Management of end-stage cancer with renal failure presents significant ethical and clinical challenges.
- Obstructive renal failure in advanced cancer necessitates interventions to improve patient survival and quality of life.
Purpose of the Study:
- To analyze survival rates and identify key selection criteria for urinary diversion in advanced cancer patients with obstructive renal failure.
Main Methods:
- Retrospective analysis of survival rates in 218 patients with advanced neoplastic disease and obstructive renal failure who underwent urinary diversion.
- Evaluation of clinical criteria for patient selection, including tumor stage, primary location, antineoplastic therapy potential, and patient consent.
Main Results:
- High mortality rates observed: 20% at 1 month, 75% at 6 months, and 98% at 1 year post-procedure.
- Urinary diversion aims to prolong survival and improve quality of life in this patient cohort.
Conclusions:
- Urinary diversion in advanced cancer patients with renal failure is associated with poor survival outcomes.
- Careful patient selection based on tumor characteristics, treatment options, and patient consent is critical.
- Further randomized, long-term studies are needed to assess both survival and quality of life impacts.